Pharmaceutical development of a lyophilised dosage form for the investigational anticancer agent Imexon using dimethyl sulfoxide as solubilising and stabilising agent

M.W.J. den Brok, B. Nuijen, C. Lutz, H.G. Opitz, J.H. Beijnen

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)1101-1114
Number of pages14
JournalJournal of Pharmaceutical Sciences
Volume94
Issue number5
Publication statusPublished - 2005

Cite this